| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total revenue | 983 | 983 | ||
| Research and development | 7,774 | 6,042 | ||
| General and administrative | 4,094 | 3,958 | ||
| Total operating expenses | 11,868 | 10,000 | ||
| Loss from operations | -10,885 | -9,017 | ||
| Interest income | 911 | 1,025 | ||
| Loss on issuance of common stock, pre-funded warrants and warrants in the 2024 pipe | 0 | 0 | ||
| Loss on amendment and cancellation of warrants | 0 | 0 | ||
| Loss on execution of the 2025 pipe | 0 | 0 | ||
| Loss (gain) on change in fair value of tranche liability | -40,748 | 31,520 | ||
| Gain on settlement of tranche liability | 0 | 0 | ||
| Other (expense) income, net (note 3) | -20,921 | 16,218 | ||
| Net income (loss) | -71,643 | 39,700 | ||
| Earnings per share, basic | -8.36 | 2.55 | ||
| Earnings per share, diluted | -8.36 | 2.55 | ||
| Weighted average number of shares outstanding, basic | 8,571 | 8,541 | ||
| Weighted average number of shares outstanding, diluted | 8,571 | 8,541 | ||
Surrozen, Inc. DE (SRZNW)
Surrozen, Inc. DE (SRZNW)